What is the Return on Assets (ROA) of Athenex this year?
The Return on Assets (ROA) of Athenex is -0.51 undefined this year.
Athenex ROA 2025
Athenex ROA
-0.51
Ticker
ATNX
ISIN
US04685N1037
WKN
A2DTE9
In 2025, Athenex's return on assets (ROA) was -0.51, a 0% increase from the 0 ROA in the previous year.
Athenex Aktienanalyse
What does Athenex do?
Athenex Inc was founded in 2003 and is headquartered in Buffalo, New York. The company specializes in the development and marketing of innovative drugs and therapies for the treatment of cancer and other serious diseases. Athenex's business model is based on collaboration with other companies and research institutions. The company works closely with academic partners to identify and develop new technologies and active ingredients. Athenex has also entered into several collaboration agreements with major pharmaceutical companies to facilitate the marketing of its products. The company has multiple divisions: Athenex Pharmaceutical Division, Athenex Oncology Division, and Athenex Pharmaceutical Technology Division. The Athenex Pharmaceutical Division focuses on the development and marketing of drugs for the treatment of cancer and other serious illnesses. The company has several promising drug candidates in its pipeline, including Oratopo, a drug for the treatment of breast cancer, and KX-2-391, a drug for the treatment of prostate cancer. The Athenex Oncology Division focuses on the development and marketing of innovative cancer treatment methods. The company has several promising therapy approaches in its pipeline, including an immunological cancer treatment based on activating the immune system to fight cancer cells. The Athenex Pharmaceutical Technology Division utilizes advanced technologies to improve the effectiveness and tolerability of drugs, including novel drug delivery systems and innovative packaging forms. Athenex also offers a wide range of products and services for the pharmaceutical industry, including drug development and manufacturing, as well as the supply of active ingredients and excipients. Overall, Athenex has a broad and interesting business model and a promising portfolio of drug candidates and therapy approaches in its pipeline. The company has also established strong partnerships with other companies and research institutions to advance its development and marketing of drugs and therapies. Athenex ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Athenex's Return on Assets (ROA)
Athenex's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Athenex's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Athenex's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Athenex’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Athenex stock
What was the ROA of Athenex compared to the previous year?
The ROA of Athenex has increased by 0% compared to the previous year.
What consequences do high ROA have for investors of Athenex?
A high ROA is advantageous for investors of Athenex, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Athenex?
A low ROA can be unfavorable for investors of Athenex as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Athenex affect the company?
An increase in ROA of Athenex can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Athenex impact the company?
A reduction in the ROA of Athenex can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Athenex?
Some factors that can influence the ROA of Athenex include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Athenex important for investors?
The ROA of Athenex is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Athenex take to improve ROA?
To improve ROA, Athenex can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Athenex pay?
Over the past 12 months, Athenex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Athenex is expected to pay a dividend of 0 USD.
What is the dividend yield of Athenex?
The current dividend yield of Athenex is .
When does Athenex pay dividends?
Athenex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Athenex?
Athenex paid dividends every year for the past 0 years.
What is the dividend of Athenex?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Athenex located?
Athenex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Athenex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Athenex from 2/14/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/14/2025.
When did Athenex pay the last dividend?
The last dividend was paid out on 2/14/2025.
What was the dividend of Athenex in the year 2024?
In the year 2024, Athenex distributed 0 USD as dividends.
In which currency does Athenex pay out the dividend?
The dividends of Athenex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Athenex
Our stock analysis for Athenex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Athenex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
